534 related articles for article (PubMed ID: 28510041)
1. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.
Deshmukh P; Unni S; Krishnappa G; Padmanabhan B
Biophys Rev; 2017 Feb; 9(1):41-56. PubMed ID: 28510041
[TBL] [Abstract][Full Text] [Related]
2. Potential Applications of NRF2 Modulators in Cancer Therapy.
Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
[TBL] [Abstract][Full Text] [Related]
3. Recent progress and applications of small molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative diseases.
Wang J; Cao Y; Lu Y; Zhu H; Zhang J; Che J; Zhuang R; Shao J
Eur J Med Chem; 2024 Jan; 264():115998. PubMed ID: 38043492
[TBL] [Abstract][Full Text] [Related]
4. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism.
Mitsuishi Y; Motohashi H; Yamamoto M
Front Oncol; 2012; 2():200. PubMed ID: 23272301
[TBL] [Abstract][Full Text] [Related]
5. Age-related cataracts: Role of unfolded protein response, Ca
Periyasamy P; Shinohara T
Prog Retin Eye Res; 2017 Sep; 60():1-19. PubMed ID: 28864287
[TBL] [Abstract][Full Text] [Related]
6. The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.
Tu W; Wang H; Li S; Liu Q; Sha H
Aging Dis; 2019 Jun; 10(3):637-651. PubMed ID: 31165007
[TBL] [Abstract][Full Text] [Related]
7. Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents.
Abed DA; Goldstein M; Albanyan H; Jin H; Hu L
Acta Pharm Sin B; 2015 Jul; 5(4):285-99. PubMed ID: 26579458
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
9. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
10. The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A; Yamamoto M
Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
[No Abstract] [Full Text] [Related]
11. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
12. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
13. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
14. p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death.
Park JS; Oh SY; Lee DH; Lee YS; Sung SH; Ji HW; Lee MJ; Lee YH; Rhee SG; Bae SH
Free Radic Res; 2016 Dec; 50(12):1408-1421. PubMed ID: 27780373
[TBL] [Abstract][Full Text] [Related]
15. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.
Ding X; Jian T; Wu Y; Zuo Y; Li J; Lv H; Ma L; Ren B; Zhao L; Li W; Chen J
Biomed Pharmacother; 2019 Feb; 110():85-94. PubMed ID: 30466006
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
18. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1.
Kobayashi A; Kang MI; Watai Y; Tong KI; Shibata T; Uchida K; Yamamoto M
Mol Cell Biol; 2006 Jan; 26(1):221-9. PubMed ID: 16354693
[TBL] [Abstract][Full Text] [Related]
19. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.
Ohta T; Iijima K; Miyamoto M; Nakahara I; Tanaka H; Ohtsuji M; Suzuki T; Kobayashi A; Yokota J; Sakiyama T; Shibata T; Yamamoto M; Hirohashi S
Cancer Res; 2008 Mar; 68(5):1303-9. PubMed ID: 18316592
[TBL] [Abstract][Full Text] [Related]
20. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]